Suven Lifesciences Jumps After Securing Patents

Subscribe to GoodReturns
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

    Shares in Suven Lifesciences jumped more than 8 per cent after the company secured product patent from countries like China, Mexico, Israel, China, Singapore and Sri Lanka. The product patent is corresponding to their new chemical entities (NCEs) for the treatment of disorders associated with Neuro degenerative diseases.

    Suven Lifesciences Jumps After Securing Patents
    The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neuro degenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia, as per BSE filing.
     

    "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally" says Venkat Jasti, CEO of Suven.

    The shares were last trading at Rs 224, up 8.61 per cent over Thursday's close.

    GoodReturns.in

    Read more about: nse suven life
    Story first published: Thursday, September 10, 2015, 13:55 [IST]
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    Get Latest News alerts from Goodreturns

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more